{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:51:06Z","timestamp":1794671466148,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010552","name":"Departament de Salut, Generalitat de Catalunya","doi-asserted-by":"publisher","award":["PERIS-2016\u20132020 SLT002\/16\/00404 and SLT006\/17\/76"],"award-info":[{"award-number":["PERIS-2016\u20132020 SLT002\/16\/00404 and SLT006\/17\/76"]}],"id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008963","name":"Sociedad Espa\u00f1ola de Oncolog\u00eda M\u00e9dica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The incidence of human papillomavirus (HPV)-related oropharyngeal cancer is increasing in some regions. Nevertheless, the epidemiology of this disease has not been extensively investigated in southern Europe. We conducted a retrospective cohort study of patients diagnosed with primary oropharyngeal cancer from 1991 to 2016. Cancer tissues underwent histopathological evaluation, DNA quality control, HPV-DNA detection and p16<jats:sup>INK4a<\/jats:sup>immunohistochemistry. Data were collected from medical records. Factors associated with HPV positivity and time trends were evaluated with multivariable Bayesian models. The adjusted prevalence of HPV-related cases in 864 patients with a valid HPV-DNA result was 9.7%, with HPV-DNA\/p16<jats:sup>INK4a<\/jats:sup>double positivity being considered. HPV-related oropharyngeal cancer was likely to occur in non-smokers and non-drinkers, to be located in the tonsil or diagnosed at advanced stages. Time-trend analysis showed an increasing risk of HPV-related oropharyngeal cancer in the most recent periods (5-year period increase of 30%). This increase was highest and with a clear increasing trend only in the most recent years (2012\u20132016). The prevalence of HPV-related oropharyngeal cancer started to sharply increase in the most recent years in our setting, as occurred two decades ago in areas where most oropharyngeal cancer cases are currently HPV-related. Our results provide a comprehensive assessment of the epidemiological landscape of HPV-related oropharyngeal cancer in a region of southern Europe.<\/jats:p>","DOI":"10.1038\/s41598-020-70118-7","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T10:03:29Z","timestamp":1596708209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe"],"prefix":"10.1038","volume":"10","author":[{"given":"M.","family":"Mena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Frias-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Taberna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Quir\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Marquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Clavero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Baena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Lloveras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Alejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mes\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Bermejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Bonfill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Aguila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Guix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hijano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Pav\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cl\u00e8ries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Alemany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,6]]},"reference":[{"key":"70118_CR1","unstructured":"IARC. IARC Monographs on the evaluation of carcinogenic risks to humans. Monograph89, 223\u2013276 (2007)."},{"issue":"4","key":"70118_CR2","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"C De Martel","year":"2017","unstructured":"De Martel, C., Plummer, M., Vignat, J. & Franceschi, S. Worldwide burden of cancer attributable to HPV by site country and HPV type. Int. J. Cancer141(4), 664\u2013670 (2017).","journal-title":"Int. J. Cancer"},{"key":"70118_CR3","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","volume":"29","author":"AK Chaturvedi","year":"2011","unstructured":"Chaturvedi, A. K. et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J. Clin. Oncol.29, 4294\u20134301 (2011).","journal-title":"J. Clin. Oncol."},{"key":"70118_CR4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/ijc.24339","volume":"125","author":"A Nasman","year":"2009","unstructured":"Nasman, A. et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral-induced carcinoma?. Int. J. Cancer125, 362\u2013366 (2009).","journal-title":"Int. J. Cancer"},{"key":"70118_CR5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/00016480903071377","volume":"130","author":"K Hannisdal","year":"2010","unstructured":"Hannisdal, K., Schj\u00f8lberg, A., De Angelis, P. M., Boysen, M. & Clausen, O. P. Human papillomavirus (HPV)-positive tonsillar carcinomas are frequent and have a favourable prognosis in males in Norway. Acta Otolaryngol.130, 293\u2013299 (2010).","journal-title":"Acta Otolaryngol."},{"issue":"9","key":"70118_CR6","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/ijc.29254","volume":"136","author":"E Garnaes","year":"2015","unstructured":"Garnaes, E. et al. A high and increasing HPV prevalence in tonsillar cancers in Eastern Denmark, 2000\u20132010: The largest registry-based study to date. Int. J. Cancer136(9), 2196\u20132203 (2015).","journal-title":"Int. J. Cancer"},{"key":"70118_CR7","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/ijc.27821","volume":"132","author":"MM Rietbergen","year":"2013","unstructured":"Rietbergen, M. M. et al. Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. Int. J. Cancer132, 1565\u20131571 (2013).","journal-title":"Int. J. Cancer"},{"issue":"29","key":"70118_CR8","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2015.61.6995","volume":"33","author":"ML Gillison","year":"2015","unstructured":"Gillison, M. L., Chaturvedi, A. K., Anderson, W. F. & Fakhry, C. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J. Clin. Oncol.33(29), 3235\u20133242 (2015).","journal-title":"J. Clin. Oncol."},{"key":"70118_CR9","first-page":"1","volume":"00","author":"M Taberna","year":"2017","unstructured":"Taberna, M. et al. Human papillomavirus-related oropharyngeal cancer. . Ann. Oncol.00, 1\u201313 (2017).","journal-title":"Ann. Oncol."},{"issue":"6","key":"70118_CR10","doi-asserted-by":"crossref","first-page":"djv03","DOI":"10.1093\/jnci\/djv403","volume":"108","author":"X Castellsagu\u00e9","year":"2016","unstructured":"Castellsagu\u00e9, X. et al. HPV Involvement in head and neck cancers: Comprehensive assessment of biomarkers in 3680 patients. J. Natl. Cancer Inst.108(6), djv03 (2016).","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"70118_CR11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ijc.28355","volume":"134","author":"JP Rodrigo","year":"2014","unstructured":"Rodrigo, J. P. et al. Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990\u20132009). Int. J. Cancer134(2), 487\u2013492 (2014).","journal-title":"Int. J. Cancer"},{"issue":"3","key":"70118_CR12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12094-013-1074-5","volume":"16","author":"L Cerezo","year":"2014","unstructured":"Cerezo, L. et al. OPC related to human papilloma virus: Incidence and prognosis in Madrid,. Clin. Transl. Oncol.16(3), 301\u2013306 (2014).","journal-title":"Clin. Transl. Oncol."},{"key":"70118_CR13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.oraloncology.2018.01.010","volume":"78","author":"M Mena","year":"2018","unstructured":"Mena, M. et al. Double positivity for HPV-DNA\/p16INK4a is the biomarker with strongest diagnostic accuracy and prognostic value for human papillomavirus related oropharyngeal cancer patients. Oral. Oncol.78, 137\u2013144 (2018).","journal-title":"Oral. Oncol."},{"issue":"1","key":"70118_CR14","doi-asserted-by":"crossref","first-page":"9320","DOI":"10.1038\/s41598-020-66323-z","volume":"10","author":"A Del Mistro","year":"2020","unstructured":"Del Mistro, A. et al. Age-independent increasing prevalence of human papillomavirus-driven oropharyngeal carcinomas in North-East Italy. Sci. Rep.10(1), 9320 (2020).","journal-title":"Sci. Rep."},{"issue":"9","key":"70118_CR15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.oraloncology.2014.05.004","volume":"50","author":"WH Westra","year":"2014","unstructured":"Westra, W. H. Detection of human papillomavirus (HPV) in clinical samples: Evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas. Oral. Oncol.50(9), 771\u2013779 (2014).","journal-title":"Oral. Oncol."},{"key":"70118_CR16","doi-asserted-by":"crossref","unstructured":"Leeper, T. J. Prediction: Tidy, Type-Safe 'prediction()' Methods. R package version 0.2.0 (2017).","DOI":"10.32614\/CRAN.package.prediction"},{"issue":"1","key":"70118_CR17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ijc.28963","volume":"136","author":"L Alemany","year":"2015","unstructured":"Alemany, L. et al. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int. J. Cancer136(1), 98\u2013107 (2015).","journal-title":"Int. J. Cancer"},{"issue":"3","key":"70118_CR18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.canep.2010.03.003","volume":"34","author":"R Cl\u00e8ries","year":"2010","unstructured":"Cl\u00e8ries, R. et al. Monitoring the decreasing trend of testicular cancer mortality in Spain during 2005\u20132019 through a Bayesian approach. Cancer Epidemiol.34(3), 244\u2013256 (2010).","journal-title":"Cancer Epidemiol."},{"key":"70118_CR19","unstructured":"Gelman, A., & Su, Y. Arm: Data Analysis Using Regression and Multilevel\/Hierarchical Models. R package version 1.9\u20133 (2016)."},{"key":"70118_CR20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.canep.2018.04.003","volume":"54","author":"L Botta","year":"2018","unstructured":"Botta, L. et al. Angelis R, et al on behalf of the RARECAREnet Working group. Bayesian estimates of the incidence of rare cancers in Europe. Cancer Epidemiol.54, 95\u2013100 (2018).","journal-title":"Cancer Epidemiol."},{"issue":"6","key":"70118_CR21","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.canep.2011.02.012","volume":"35","author":"DL de Souza","year":"2011","unstructured":"de Souza, D. L., P\u00e9rez, M. M. & Curado, M. P. Predicted incidence of oral cavity, oropharyngeal, laryngeal, and hypopharyngeal cancer in Spain and implications for cancer control. Cancer Epidemiol.35(6), 510\u2013514 (2011).","journal-title":"Cancer Epidemiol."},{"issue":"8","key":"70118_CR22","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay, J. et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int. J. Cancer144(8), 1941\u20131953 (2019).","journal-title":"Int. J. Cancer"},{"issue":"Suppl 5","key":"70118_CR23","doi-asserted-by":"crossref","first-page":"F34","DOI":"10.1016\/j.vaccine.2012.05.070","volume":"30","author":"ML Gillison","year":"2012","unstructured":"Gillison, M. L. et al. Human papillomavirus and diseases of the upper airway: Head and neck cancer and respiratory papillomatosis. Vaccine30(Suppl 5), F34\u2013F54 (2012).","journal-title":"Vaccine"},{"key":"70118_CR24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.oraloncology.2016.06.006","volume":"60","author":"AK Chaturvedi","year":"2016","unstructured":"Chaturvedi, A. K., D\u2019Souza, G., Gillison, M. L. & Katki, H. A. Burden of HPV-positive oropharynx cancers among ever and never smokers in the U.S. Population. Oral Oncol60, 61\u20137 (2016).","journal-title":"Oral Oncol"},{"key":"70118_CR25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.oraloncology.2018.06.013","volume":"83","author":"EM Rettig","year":"2018","unstructured":"Rettig, E. M. et al. Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of human papillomavirus is attenuated among older patients: Analysis of the national cancer database. Oral. Oncol.83, 147\u2013153 (2018).","journal-title":"Oral. Oncol."},{"issue":"14","key":"70118_CR26","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1002\/cncr.31385","volume":"124","author":"MJ Windon","year":"2018","unstructured":"Windon, M. J. et al. Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults. Cancer124(14), 2993\u20132999 (2018).","journal-title":"Cancer"},{"issue":"12","key":"70118_CR27","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1158\/1055-9965.EPI-14-0580","volume":"23","author":"JD Combes","year":"2014","unstructured":"Combes, J. D., Chen, A. A. & Franceschi, S. Prevalence of human papillomavirus in cancer of the oropharynx by gender. Cancer Epidemiol. Biomark. Prev.23(12), 2954\u20132958 (2014).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"1","key":"70118_CR28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12094-013-1060-y","volume":"16","author":"R Cleries","year":"2014","unstructured":"Cleries, R. et al. Time trends of cancer incidence and mortality in Catalonia during 1993\u20132007. Clin. Transl. Oncol.16(1), 18\u201328 (2014).","journal-title":"Clin. Transl. Oncol."},{"issue":"12","key":"70118_CR29","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1002\/ijc.29082","volume":"136","author":"AR Giuliano","year":"2015","unstructured":"Giuliano, A. R. et al. EUROGIN 2014 roadmap: Differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int. J. Cancer136(12), 2752\u20132760 (2015).","journal-title":"Int. J. Cancer"},{"issue":"1","key":"70118_CR30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/ije\/dyp350","volume":"39","author":"JE Heck","year":"2010","unstructured":"Heck, J. E. et al. Sexual behaviours and the risk of head and neck cancers: A pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int. J. Epidemiol.39(1), 166\u2013181 (2010).","journal-title":"Int. J. Epidemiol."},{"issue":"6","key":"70118_CR31","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/jmv.23282","volume":"84","author":"X Castellsagu\u00e9","year":"2012","unstructured":"Castellsagu\u00e9, X. et al. Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: The CLEOPATRE study. J. Med. Virol.84(6), 947\u2013956 (2012).","journal-title":"J. Med. Virol."},{"issue":"7","key":"70118_CR32","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1158\/1940-6207.CAPR-15-0101","volume":"8","author":"C Fakhry","year":"2015","unstructured":"Fakhry, C., Andersen, K. K., Christensen, J., Agrawal, N. & Eisele, D. W. The impact of tonsillectomy upon the risk of oropharyngeal carcinoma diagnosis and prognosis in the danish cancer registry. Cancer Prev. Res. (Phila.)8(7), 583\u2013589 (2015).","journal-title":"Cancer Prev. Res. (Phila.)"},{"issue":"6","key":"70118_CR33","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1158\/1055-9965.EPI-15-0907","volume":"25","author":"A Chaturvedi","year":"2016","unstructured":"Chaturvedi, A. et al. Tonsillectomy and incidence of oropharyngeal cancers. Cancer Epidemiol. Biomark. Prev.25(6), 944\u2013950 (2016).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"22","key":"70118_CR34","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.1158\/0008-5472.CAN-16-0633","volume":"76","author":"AG Schache","year":"2016","unstructured":"Schache, A. G. et al. HPV-related oropharynx cancer in the United Kingdom: An evolution in the understanding of disease etiology. Cancer Res.76(22), 6598\u20136606 (2016).","journal-title":"Cancer Res."},{"key":"70118_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pvr.2017.05.002","volume":"4","author":"L Haeggblom","year":"2017","unstructured":"Haeggblom, L., Ramqvist, T., Tommasino, M., Dalianis, T. & N\u00e4sman, A. Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years. Papillomavirus Res4, 1\u201311 (2017).","journal-title":"Papillomavirus Res"},{"issue":"6","key":"70118_CR36","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/bjc.2014.42","volume":"110","author":"C Gr\u00f8nh\u00f8j Larsen","year":"2014","unstructured":"Gr\u00f8nh\u00f8j Larsen, C. et al. Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: A systematic review. Br. J. Cancer110(6), 1587\u20131594 (2014).","journal-title":"Br. J. Cancer"},{"issue":"35","key":"70118_CR37","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/PAS.0b013e3182116a45","volume":"2011","author":"F Perrone","year":"2011","unstructured":"Perrone, F. et al. Isolating p16 positive\/HPV negative oropharyngeal cancer: An effort worth making. Am. J. Surg. Pathol.2011(35), 774\u2013777 (2011).","journal-title":"Am. J. Surg. Pathol."},{"issue":"7","key":"70118_CR38","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/PAS.0b013e318253a2d1","volume":"36","author":"RC Jordan","year":"2012","unstructured":"Jordan, R. C. et al. Validation of methods for OPC HPV status determination in US cooperative group trials. Am. J. Surg. Pathol.36(7), 945\u2013954 (2012).","journal-title":"Am. J. Surg. Pathol."},{"issue":"8","key":"70118_CR39","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s00405-015-3728-0","volume":"273","author":"A Coordes","year":"2016","unstructured":"Coordes, A. et al. Meta-analysis of survival in patients with HNSCC discriminates risk depending on combined HPV and p16 status. Eur. Arch. Otorhinolaryngol.273(8), 2157\u20132169 (2016).","journal-title":"Eur. Arch. Otorhinolaryngol."},{"issue":"10","key":"70118_CR40","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1002\/ijc.28580","volume":"134","author":"MM Rietbergen","year":"2014","unstructured":"Rietbergen, M. M. et al. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas. Int. J. Cancer134(10), 2366\u20132372 (2014).","journal-title":"Int. J. Cancer"},{"key":"70118_CR41","unstructured":"Galceran, J., Ameijide, A., Alemany, L., Carulla, M., Marcos, R., Vilardell, L., et al. Incidence and mortality of neoplasias related to Human papillomavirus in Catalonia. In XXXV Scientific Meeting of the Spanish Society of Epidemiology (SEE), Oral Presentation, (2017)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70118-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70118-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70118-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T11:22:21Z","timestamp":1723375341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70118-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["70118"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-70118-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,6]]},"assertion":[{"value":"26 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RM has received personal fees and non-financial support from Merck, and personal fees from Astra Zeneca and MSD. MT has received scientific advisory board fees, speaker\u2019s fees, travel grants or non-financial support from Merck, Astra Zeneca, Nanobiotics, MSD and Bristol Meyers. Cancer Epidemiology Research Program (LA, MM, JF, SM, ST, BQ, OC, MT, MTo, MP) has received sponsorship for grants from Merck and co, Roche, Reig-jofre, IDT, Seegene, Hologic and GSK. The rest of authors have declared no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13219"}}